![Erick Lucera](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erick Lucera
Directeur Financier/CFO chez
DYNE THERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Erick J.
Lucera is Independent Director at Beyond Air, Inc. since 2017 and Director at Beyond Air Ltd. since 2017.
Mr. Lucera is Independent Director at SAB Biotherapeutics, Inc. since 2023.
Mr. Lucera is Chief Financial Officer & Treasurer at Dyne Therapeutics, Inc. starting in 2025.
Former roles include Chief Executive Officer at Triathlon Fund Management LLC from 2004 to 2007, Director at Bone Biologics Corp.
from 2021 to 2024, Vice President at Eaton Vance Management from 2008 to 2012, Principal at Independence Investments LLC from 1995 to 2004, Vice President-Corporate Development at Nuwellis, Inc. in 2012, Portfolio Manager at Triathlon Life Sciences Fund LP, Vice President-Corporate Development at Aratana Therapeutics, Inc. from 2012 to 2015, Chief Financial Officer, Secretary & Treasurer at Valeritas Holdings, Inc. from 2016 to 2019, Principal at Pricewaterhouse & Co. from 1990 to 1993, Chief Financial Officer at AVEO Pharmaceuticals, Inc. from 2020 to 2023, Chief Financial Officer, Secretary & Treasurer at Viventia Bio, Inc. from 2015 to 2016, and Chief Financial Officer & Executive Vice President at Editas Medicine, Inc. from 2023 to 2025.
Education includes graduate degree from Boston College in 1999, MBA from Indiana University in 1995, undergraduate degree from the University of Delaware in 1990, and undergraduate studies at Harvard University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DYNE THERAPEUTICS INC 0,08 % | 13/05/2026 | 123 925 ( 0,08 % ) | 2 M $ | 31/05/2026 |
BEYOND AIR, INC. 0,02 % | 20/04/2026 | 2 178 ( 0,02 % ) | 1 002 $ | 31/05/2026 |
| 02/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Erick Lucera
| Sociétés | Poste | Début |
|---|---|---|
| BEYOND AIR, INC. | Directeur/Membre du Conseil | 10/08/2017 |
| SAB BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/04/2023 |
| DYNE THERAPEUTICS, INC. | Directeur Financier/CFO | 31/03/2025 |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Operates as a clinical-stage medical device and biopharmaceutical company | Directeur/Membre du Conseil | 01/08/2017 |
Anciens postes connus de Erick Lucera
| Sociétés | Poste | Fin |
|---|---|---|
| EDITAS MEDICINE, INC. | Directeur Financier/CFO | 28/03/2025 |
| BONE BIOLOGICS CORPORATION | Directeur/Membre du Conseil | 11/01/2024 |
| AVEO PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/02/2023 |
| VALERITAS HOLDINGS, INC. | Directeur Financier/CFO | 01/12/2019 |
Viventia Bio, Inc.
 Viventia Bio, Inc. BiotechnologyHealth Technology Focuses on designing, engineering and developing targeted protein therapeutics | Directeur Financier/CFO | 01/08/2016 |
Formation de Erick Lucera
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Eaton Vance Management
 Eaton Vance Management Investment ManagersFinance EVM invests in a wide range of financial instruments and asset classes. Their evaluation of investment alternatives places primary emphasis and reliance upon fundamental analysis of issuers of equity and debt securities; political, economic, and industry developments; money and capital market conditions, with attention to interest rate patterns; and any other factors that, in EVM’s judgment, may have an impact on the value of an investment. | Finance |
Independence Investments LLC
 Independence Investments LLC Investment ManagersFinance Independence follows a multi-dimensional investment process applying fundamental research and quantitative modeling to create return predictions. In fundamental research, analysts determine how economic and competitive forces are likely to shape the prospects for each of the companies in their investment universe. The analysts interview the management of these companies, as well as suppliers, customers, competitors and other industry experts. Quantitative research is then used to translate these fundamental insights into computer-based methods for stock selection. Independence's investment philosophy and process seeks to minimize style and sector biases. | Finance |
Nuwellis, Inc.
 Nuwellis, Inc. Medical SpecialtiesHealth Technology Develops heart assist devices | Health Technology |
Triathlon Fund Management LLC
 Triathlon Fund Management LLC Investment ManagersFinance Triathlon Fund Management invests in stocks in North America and Europe focusing on the biotechnology sector. They are primarily small-cap investors that maintain a high turnover rate. | Finance |
Triathlon Life Sciences Fund LP
 Triathlon Life Sciences Fund LP Investment ManagersFinance Private Equity Fund | Finance |
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialization therapeutics for dogs & cats | Health Technology |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Develops and commercializes insulin drug delivery devices | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pricewaterhouse & Co.
 Pricewaterhouse & Co. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Bone Biologics Corp.
 Bone Biologics Corp. Medical SpecialtiesHealth Technology Develops ortho biologic products | Health Technology |
Beyond Air, Inc.
 Beyond Air, Inc. Medical SpecialtiesHealth Technology Developing a platform of nitric oxide generators and delivery systems | Health Technology |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Operates as a clinical-stage medical device and biopharmaceutical company | Health Technology |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Focuses on designing, engineering and developing targeted protein therapeutics | Health Technology |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
